Union Medical Healthcare Ltd (2138)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 0.510 |
|---|---|
| 52-week range | 0.340 – 0.730 |
| Return, 1 month / 3 months | −1.9% / +37.8% |
| Return, 1 year / 3 years | −29.2% / −82.7% |
| Trend | Uptrend |
| RSI (14) | 46 |
| Volatility (1 year) | 50.2% |
| Worst drawdown (1 year) | -52.1% |
| Average daily value traded | 0.27M HKD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Union Medical Healthcare is a Hong Kong based provider of medical and aesthetic services. Through its clinics and service centres, it offers medical beauty treatments, aesthetic procedures and health check services to individual customers in Hong Kong. The company operates under its own brand names and serves consumers seeking cosmetic and wellness related care. Its business centres on delivering these treatments through a network of outlets in the local market.
Union Medical Healthcare Ltd trades under the code 2138 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Union Medical Healthcare Ltd (2138) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 0.510 on 20 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 818 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 29.2% and over the last three months it rose 37.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 5.7% | ||
| From 52-week high | -30.1% | ||
| Momentum | 69 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 37.8% | ||
| 6-month return | 4.1% | ||
| 12-month return, skipping the last month | -27.8% | ||
| Stability (higher is calmer) | 51 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 50.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -52.1% | ||
| Liquidity | 49 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.27M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −7.3% |
|---|---|
| 1 month | −1.9% |
| 3 months | +37.8% |
| 6 months | +4.1% |
| 1 year | −29.2% |
| 3 years | −82.7% |
| 5 years | – |
Signals
| 50-day / 200-day average | 0.486 / 0.482 |
|---|---|
| Golden / death cross (60 days) | Golden, 1 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.027 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Dec 2024 | HKD 0.0100 |
| 28 Dec 2023 | HKD 0.0050 |
| 4 Sep 2023 | HKD 0.0420 |
| 28 Dec 2022 | HKD 0.0580 |
| 5 Sep 2022 | HKD 0.0420 |
| 30 Dec 2021 | HKD 0.1020 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.